Company Filing History:
3 out of 159 
3 out of 100 
1 out of 8 Years Active: 2013-2020
Title: Jindong Liang: Innovator in Cancer Treatment
Introduction
Jindong Liang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of cancer treatment through his innovative research and development of drug conjugates. With a total of 3 patents, Liang's work focuses on enhancing the efficacy of cancer therapies.
Latest Patents
Liang's latest patents include groundbreaking advancements in ligand-cytotoxic drug conjugates. One of his notable inventions is a ligand-cytotoxic drug conjugate of general formula Pc-(X-Y-D), which can be utilized to treat cancer via receptor modulation. Additionally, he has developed an anti-c-Met antibody and an anti-c-Met antibody-cytotoxic drug conjugate. These inventions are designed to improve pharmaceutical compositions for cancer treatment, utilizing humanized antibodies or antigen binding fragments.
Career Highlights
Throughout his career, Jindong Liang has worked with esteemed companies such as Jiangsu Hengrui Medicine Company Ltd. and Shanghai Hengrui Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to collaborate on various innovative projects aimed at advancing cancer therapies.
Collaborations
Liang has collaborated with notable colleagues in the field, including Fanglong Yang and Yali Wang. Their combined expertise has contributed to the development of effective cancer treatment solutions.
Conclusion
Jindong Liang's contributions to cancer treatment through his innovative patents and collaborations highlight his role as a leading inventor in the pharmaceutical industry. His work continues to pave the way for advancements in cancer therapies.